首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   360858篇
  免费   34332篇
  国内免费   24579篇
耳鼻咽喉   3024篇
儿科学   4531篇
妇产科学   4269篇
基础医学   38842篇
口腔科学   5952篇
临床医学   49630篇
内科学   49154篇
皮肤病学   3549篇
神经病学   17809篇
特种医学   13223篇
外国民族医学   170篇
外科学   33619篇
综合类   67372篇
现状与发展   85篇
一般理论   35篇
预防医学   26856篇
眼科学   9729篇
药学   39506篇
  406篇
中国医学   23761篇
肿瘤学   28247篇
  2024年   1257篇
  2023年   5493篇
  2022年   14181篇
  2021年   17776篇
  2020年   13828篇
  2019年   11328篇
  2018年   12037篇
  2017年   11491篇
  2016年   10514篇
  2015年   16380篇
  2014年   20351篇
  2013年   19389篇
  2012年   28246篇
  2011年   31276篇
  2010年   20700篇
  2009年   16898篇
  2008年   20735篇
  2007年   20473篇
  2006年   19802篇
  2005年   18639篇
  2004年   12211篇
  2003年   11170篇
  2002年   9332篇
  2001年   7913篇
  2000年   7812篇
  1999年   7452篇
  1998年   4548篇
  1997年   4489篇
  1996年   3592篇
  1995年   3285篇
  1994年   2732篇
  1993年   1756篇
  1992年   2198篇
  1991年   1867篇
  1990年   1543篇
  1989年   1332篇
  1988年   1191篇
  1987年   1046篇
  1986年   842篇
  1985年   642篇
  1984年   402篇
  1983年   278篇
  1982年   179篇
  1981年   180篇
  1980年   129篇
  1979年   162篇
  1977年   61篇
  1975年   58篇
  1974年   64篇
  1972年   58篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
BACKGROUND: Ankle brachial index(ABI)is widely involved in researches and clinical application of peripheral vascular injury of patients with diabetes (DM);however ,the application in cerebral infarction(CI)is rare.OBJECTIVE: To investigate the possible risk factor of cerebral infarction plus peripheral arterial disease(PAD),compare metabolic characteristics of patients who having CI plus PAD or only having CI,and understand the significance of ABI on screening and diagnosing CI plus PAD of lower limb.DESIGN: Contrast observation based on CI patients.SETTING: Deparment of Neurology,Nanxishan Hospital of Guangxi Zhang Autonomous Region.PARTICIPANTS:A total of 124 CI patients were selected from Department of Neurology.Nanxishan Hospital of Guangxi Zhuang Autonomous Region from July 2005 to April 2006,including 72 males and 52 females aged from 45 to 88 years.All patients met the diagnostic criteria of cerebrovascular disease established by National Academic Conference of Cerebrovascular Diseases in 1995 and determined as cerebral infarction with MRI or CT examination.All patients provided informed consent.There were 46 cases(37.2%)with CI plus PAD and 78 cases(62.8%)only with CI.METHODS: Blood pressure of bilateral ankles and upper extremities was measured at plain clinostatism with DINAMAP blood pressure monitor(GE Company).The ratio between average systolic pressure of lateral ankle and average systolic pressure of both upper extremities was regarded as ABI.The normal ABI was equal to or more than 0.9.If ABI<0.9 occurred at one side,patients were diagnosed as PAD.On the second morning after hospitalization,blood was collected to measure fasting blood glucose(FBG),2-hour postprandial blood glucose(PBG2h),glycosylated hemoglobin(HbAlc),triglycerides(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C)and low-density lipoprotein cholesterol(LDL-C).Among them,blood glucose.lipid and other biochemical markers were measured with enzyme chemistry assay and HbA1c was measured with HbA1c meter based on high liquid phase.Measurement data and enumeration data were compared with t test and Chi-square test.and multiple factors were deat with Logistic regression analysis and multivariate linear regression analysis.MAIN OUTCOME MEASURES: Results of correlation between ABI and metabolic markers with multivariate linear regression analysis;risk factors of CI plus PAD with Logistic regression analysis;comparisons of metabolic markers between PAD and non-PAD patients.RESULTS:All 124 patients with acute CI were involved in the final analysis.①Comparisons of metabolic markers:Levels of serum LDL-C and uric acid(UA)were higher of PAD patients than those of non-PAD patients(t=2.051 9,3.339 1,P<0.05);however,there were no significant differences among other metabolic markers(P>0.05).②Results of multivariate linear regression analysis:PBG2h,LDL.C and UA were obvious correlation with ABI of posterior tibial artery of lower limb and dorsal pedis artery rpartial regression coefficient:-0.231 to-1.010,P<0.05).③Risk factors of CI plus PAD with Logistic regression analysis:Age.Smoking history,sum of CI focus(≥3)and LDL-C were independent risk factor of CI plus PAD(OR=1.524-5.422,P<0.05-0.01 ).CONCLUSION:①Levels of serum LDL-C and UA of patients with CI plus PAD are high.②ABI of lower limbs is correlation with PBG2h,LDL-C and UA.In addition,measuring ABI is beneficial for early diagnosing PAD of lower limbs of patients who have poorly controlled blood glucose,abnormal lipid and poor renal function.③Age,LDL-C and sum of CI focus(≥3)are independent risk factors of CI plus PAD.It is of significance for screening non-PAD patients to evaluate risk degrees and prognosis and select therapeutic methods based on ABI measurement.  相似文献   
102.
103.
The study of brain function using MRI relies on acquisition techniques that are sensitive to different aspects of the hemodynamic response contiguous to areas of neuronal activity. For this purpose different contrasts such as arterial spin labeling (ASL) and blood oxygenation level dependent (BOLD) functional MRI techniques have been developed to investigate cerebral blood flow (CBF) and blood oxygenation, respectively. Analysis of such data typically proceeds by separate, linear modeling of the appropriate CBF or BOLD time courses. In this work an approach is developed that provides simultaneous inference on hemodynamic changes via a nonlinear physiological model of ASL data acquired at multiple echo times. Importantly, this includes a significant contribution by changes in the static magnetization, M, to the ASL signal. Inference is carried out in a Bayesian framework. This is able to extract, from dual-echo ASL data, probabilistic estimates of percentage changes of CBF, R(2) (*), and the static magnetization, M. This approach provides increased sensitivity in inferring CBF changes and reduced contamination in inferring BOLD changes when compared with general linear model approaches on single-echo ASL data. We also consider how the static magnetization, M, might be related to changes in CBV by assuming the same mechanism for water exchange as in vascular space occupancy.  相似文献   
104.
网络环境下医学专题检索服务的深化   总被引:3,自引:2,他引:1  
分析网络环境下图书馆定题服务的现状和价值,提出跟踪服务的方式,进行分阶段的、具体的定题服务,并实例分析分阶段定题服务的优势。  相似文献   
105.
对鲜山药中水溶性粗多糖的提取工艺进行了研究,通过单因素试验和L9(34)正交试验,研究了料液比、提取温度、时间和乙醇体积分数对粗多糖得率的影响,极差分析及方差分析结果表明提取温度和料液比是影响山药粗多糖提取的主要因素,较优的工艺为料液比1 g:9 mL,温度50 ℃,时间2.5 h,乙醇体积分数75%,在此工艺条件下,鲜山药粗多糖得率为0.2449%(以鲜山药质量计).  相似文献   
106.
目的建立胰胆管合流异常的动物模型。方法选用健康杂种猫10只。术前禁食12 h,3.5%戊巴比妥钠麻醉后,取上腹正中切口约6 cm切开各层至腹腔。于胆总管入十二指肠处旁边,切开胰腺背膜,解剖胰管;靠近十二指肠处分别纵向切开胰管、胆管长约4~6 mm的切口。6-0线间断吻合切口,造成类似人类的胰胆管合流的共同通道。术后20天胆道造影。结果术后动物精神、食欲良好,无萎靡、烦燥等表现,造影显示胰胆管合流共同通道延长。结论本动物模型最接近于人类的胰胆管合流异常生理,优于其他动物模型。  相似文献   
107.
外科学教学中的审美教育   总被引:1,自引:0,他引:1  
医学审美教育是医学生全面素质教育不可分割的组成部分,笔者结合长期外科教学实践,阐述了在外科学教学中运用医学美学原理对外科学的美进行开发和挖掘,使医学生在熟练掌握外科学基本理论和基本技能的同时,潜移默化地接受美的教育,美的熏陶,更能激发他们对外科学的热爱和兴趣,达到全面提高医学生整体素质的目的。  相似文献   
108.
心房颤动的导管消融治疗   总被引:9,自引:0,他引:9  
心房颤动(简称“房颤”)是心血管疾病中无论在控制症状方面还是改善预后方面均不理想的病种。房颤的导管消融作为一种新的治疗手段,从10年前诞生之日起就引发了房颤治疗的革命,近2年来,越来越多的国内外医学中心已将其作为房颤的常规治疗。本文就现阶段如何选择房颤导管消融治疗的适应证作简要评价。1目前的方法简介由于迄今的资料充分证实房颤的起源90%以上位于肺静脉及其与左房后壁的过渡区域(肺静脉前庭),导管根治房颤的方法也就集中在将该区域与左房之间的电学传导阻断。目前的主流方法是在三维标测系统CARTO或NavX指导下行肺静脉隔…  相似文献   
109.
谷氨酰胺在危重病患者中的应用   总被引:3,自引:0,他引:3  
目的探讨危重病患者中早期经静脉应用谷氨酰胺(glutamine,Gl)的临床价值。方法42例患者随机分成两组(对照组和Gln组),Gln组进行Gln治疗(100mL/d,共7d)。治疗前后检测患者体质量、白蛋白、谷胱甘肽(GSH)、握力的变化和肠功能不全的发生率。结果体质量两组治疗前后比较差异无显著性(P〉0.05)。白蛋白、握力和GSH Gl治疗后非常显著高于治疗前(P〈0.01);白蛋白对照组治疗后较治疗前显著增高(P〈0.05),但握力和GSH治疗前后均无显著变化(P〉0.05);肠功能不全的发生率Gln组为4.8%,显著低于对照组(28.6%,P〈0.05)。结论在危重病患者疾病早期通过静脉途径外源性地补充Gln,有效改善了患者的营养状况;使患者血浆中的GSH水平增高,加强了机体的抗氧化能力;减少了患者肠功能不全的发生率。  相似文献   
110.
目的观察尿激酶(天普洛欣)对频发的短暂性脑缺血发作(TIA)的疗效。方法124例频发TIA患者随机分为尿激酶冲击治疗的尿激酶组(68例)和常规治疗的对照组(56例)。结果尿激酶组治疗后24小时、3天和15天内TIA发作的控制率分别为67.6%、89.7%和97.1%,均高于对照组的14.3%、76.8%和85.7%(P<0.01)。结论早期应用尿激酶冲击治疗能迅速控制频发TIA发作,明显改善重症患者的预后。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号